MersV1, PubMed, Curation, bibRecord, 001789

MERS vaccine is technically feasible, but is it commerically feasible?

Identifieur interne : 001789 ( PubMed/Curation ); précédent : 001788; suivant : 001790

MERS vaccine is technically feasible, but is it commerically feasible?

Auteurs : Eva M. Riedmann

Source :

Human vaccines & immunotherapeutics [ 2164-554X ] ; 2014.

RBID : pubmed:25396231

Descripteurs français

KwdFr :
- Coronavirus du syndrome respiratoire du Moyen-Orient (immunologie), Découverte de médicament (économie), Humains, Infections à coronavirus (), Infections à coronavirus (immunologie), Vaccins antiviraux (isolement et purification), Vaccins antiviraux (économie).
MESH :
- immunologie : Coronavirus du syndrome respiratoire du Moyen-Orient, Infections à coronavirus.
- isolement et purification : Vaccins antiviraux.
- économie : Découverte de médicament, Vaccins antiviraux.
- Humains, Infections à coronavirus.

English descriptors

KwdEn :
- Coronavirus Infections (immunology), Coronavirus Infections (prevention & control), Drug Discovery (economics), Humans, Middle East Respiratory Syndrome Coronavirus (immunology), Viral Vaccines (economics), Viral Vaccines (isolation & purification).
MESH :
- chemical , economics : Viral Vaccines.
- economics : Drug Discovery.
- immunology : Coronavirus Infections, Middle East Respiratory Syndrome Coronavirus.
- chemical , isolation & purification : Viral Vaccines.
- prevention & control : Coronavirus Infections.
- Humans.

PubMed: 25396231

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001789

Links to Exploration step

pubmed:25396231

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MERS vaccine is technically feasible, but is it commerically feasible?</title>
<author><name sortKey="Riedmann, Eva M" sort="Riedmann, Eva M" uniqKey="Riedmann E" first="Eva M" last="Riedmann">Eva M. Riedmann</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25396231</idno>
<idno type="pmid">25396231</idno>
<idno type="wicri:Area/PubMed/Corpus">001789</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001789</idno>
<idno type="wicri:Area/PubMed/Curation">001789</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001789</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">MERS vaccine is technically feasible, but is it commerically feasible?</title>
<author><name sortKey="Riedmann, Eva M" sort="Riedmann, Eva M" uniqKey="Riedmann E" first="Eva M" last="Riedmann">Eva M. Riedmann</name>
</author>
</analytic>
<series><title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Drug Discovery (economics)</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus (immunology)</term>
<term>Viral Vaccines (economics)</term>
<term>Viral Vaccines (isolation & purification)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient (immunologie)</term>
<term>Découverte de médicament (économie)</term>
<term>Humains</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Vaccins antiviraux (isolement et purification)</term>
<term>Vaccins antiviraux (économie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Drug Discovery</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Découverte de médicament</term>
<term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Infections à coronavirus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25396231</PMID>
<DateCompleted><Year>2015</Year>
<Month>06</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<Issue>6</Issue>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Human vaccines & immunotherapeutics</Title>
<ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
</Journal>
<ArticleTitle>MERS vaccine is technically feasible, but is it commerically feasible?</ArticleTitle>
<Pagination><MedlinePgn>1429-30</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riedmann</LastName>
<ForeName>Eva M</ForeName>
<Initials>EM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Hum Vaccin Immunother</MedlineTA>
<NlmUniqueID>101572652</NlmUniqueID>
<ISSNLinking>2164-5515</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25396231</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001789 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001789 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25396231
   |texte=   MERS vaccine is technically feasible, but is it commerically feasible?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25396231" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

MERS vaccine is technically feasible, but is it commerically feasible?

MERS vaccine is technically feasible, but is it commerically feasible?

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki